Qualcomm/Alphawave: Deal Could Become Flashpoint as Worries About UK’s Tech Economy Mount

Published on Jun 17, 2025

Qualcomm’s (QCOM) proposed $2.4 billion acquisition of Alphawave Semi (LSE: AWE) threatens to undercut the UK plan to rebuild domestic artificial intelligence and semiconductor capacity while also exposing deep structural weaknesses in its tech economy, several international trade and national security experts said.

Draft Report: EC Says Boosting Scale of Defense Sector Crucial for Competitiveness

The European Union is seeking to boost its defense competitiveness by removing legal and bureaucratic barriers, stimulating investment, and making the sector more self-reliant, according to a draft...

Jun 17, 2025 Read Now >

BlackRock/Allete: PE Firm’s Attempted Utility Takeover Generates Opposition in Minnesota

A $6.2 billion deal that would hand BlackRock (BLK) control of Allete’s (ALE) Minnesota Power, the second-largest electric utility in the state, has prompted concerns that the private equity...

Jun 16, 2025 Read Now >

The Asia Antitrust Agenda: SAMR Warns of Risks in Semiconductor Materials, Patent Database Sectors; HKCC Ends Auto-Fuel Supplier Probe; Japanese Regulator Releases Generative AI Findings; KTFC Fines Temu

SAMR flags antitrust risks in semiconductor materials, patent database sectors. China’s State Administration for Market Regulation (SAMR), the antitrust authority, warned in its annual report of...

Jun 16, 2025 Read Now >

Qualcomm/Alphawave: Deal Could Become Flashpoint as Worries About UK’s Tech Economy Mount

RELATED ARTICLES | Editor’s picks

Draft Report: EC Says Boosting Scale of Defense Sector Crucial for Competitiveness

BlackRock/Allete: PE Firm’s Attempted Utility Takeover Generates Opposition in Minnesota

The Asia Antitrust Agenda: SAMR Warns of Risks in Semiconductor Materials, Patent Database Sectors; HKCC Ends Auto-Fuel Supplier Probe; Japanese Regulator Releases Generative AI Findings; KTFC Fines Temu

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.